Nektar TherapeuticsNKTRNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank50
3Y CAGR-37.4%
5Y CAGR-39.2%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-37.4%/yr
vs -32.0%/yr prior
5Y CAGR
-39.2%/yr
Consistent
Acceleration
-5.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $89.83M | +47.9% |
| 2024 | $60.74M | -53.6% |
| 2023 | $130.99M | -64.3% |
| 2022 | $366.64M | -46.0% |
| 2021 | $679.51M | -36.9% |
| 2020 | $1.08B | -23.3% |
| 2019 | $1.41B | -18.2% |
| 2018 | $1.72B | +1855.6% |
| 2017 | $87.83M | -0.3% |
| 2016 | $88.13M | - |